Baltic Export, EU – Baltic States, Good for Business, Latvia, Markets and Companies, Medicine
International Internet Magazine. Baltic States news & analytics
Friday, 09.05.2025, 19:58
Kalceks pharmaceutical company manufactures products worth EUR 24.6 mln in H1
BC, Riga, 15.09.2020.
Print version

Kalceks pharmaceutical company in the first six months of this year manufactured products worth EUR 24.6 million, which is by EUR 19.8 million or five times more year-on-year, LETA learned from the company.
![]() |
---|
In 2019, the company manufactured products worth EUR 18.1 million, growing by EUR 8.1 million from 2018.
In the first six months of this year Kalceks sold its products in Europe, Asia and other countries of the world, with 80% of its exports going to the EU countries.
Kalceks board chairman Egils Kopstals said that Kalceks products are available in Latvia and 53 countries of the world. The company plans to increase the number of Asian partner countries, both Americas.
In 2019, Kalceks turnover amounted to EUR 59.98 million, while the company's profit stood at EUR 1.32 million.
Kalceks was registered in 1992 and its share capital is EUR 1,750,071. The company's beneficial owners are Kirovs Lipmans, Anna Lipmane and Filips Lipmans.
Other articles:
- 28.01.2022 BONO aims at a billion!
- 26.08.2021 LLC Dizozols Investments finalizes investment attraction deal with Crowdestor with record-high profits
- 13.02.2021 Моя жизнь в газете. Очерки по новейшей истории Латвии. Глава 1
- 25.01.2021 Как банкиры 90-х делили «золотую милю» в Юрмале
- 30.12.2020 Накануне 25-летия Балтийский курс/The Baltic Course уходит с рынка деловых СМИ
- 30.12.2020 On the verge of its 25th anniversary, The Baltic Course leaves business media market
- 30.12.2020 Business Education Plus предлагает анонсы бизнес-обучений в январе-феврале 2021 года
- 30.12.2020 Hotels showing strong interest in providing self-isolation service
- 30.12.2020 EU to buy additional 100 mln doses of coronavirus vaccine
- 30.12.2020 ЕС закупит 100 млн. дополнительных доз вакцины Biontech и Pfizer